Complement System and Activation Pathways

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

In a scenario where a patient presents with a deficiency in C3 and C4, leading to recurrent infections, which of the following complement pathway dysfunctions is MOST likely the primary immunological mechanism?

  • Selective impairment of the terminal lytic pathway, specifically affecting the assembly of the membrane attack complex (MAC) and increasing susceptibility to Neisseria infections.
  • Impaired opsonization due to the absence of C3b, affecting phagocytosis of encapsulated bacteria primarily targeted by the alternative pathway.
  • Overactivation of the alternative pathway, leading to consumption of C3 and C4, and subsequent dysregulation of the complement cascade.
  • A combined defect in both classical and mannan-binding lectin (MBL) pathways, disrupting early steps of complement activation and leading to inefficient C3 convertase generation. (correct)
  • Defective classical pathway activation due to dysfunctional C1qrs complex formation, preventing downstream cleavage of C2 and C4 and subsequent C3 convertase formation.

A researcher is investigating novel therapeutic targets within the complement system. Targeting which factor would MOST selectively inhibit the alternative pathway while preserving the functionality of the classical and mannan-binding lectin pathways?

  • MASP-2
  • C9
  • C4
  • Factor B (correct)
  • C1q

If a patient's serum sample demonstrates normal levels of all complement components (C1-C9, Factor B, Factor D, Properdin) but exhibits severely impaired complement-mediated lysis in vitro. Which of the following genetic defects is MOST likely responsible?

  • A missense mutation in the C8 gene, resulting in a structurally abnormal C8 protein that is unable to properly insert into the cell membrane. (correct)
  • A mutation affecting the glycosylation of C3b, preventing its proper interaction with Factor B.
  • A homozygous deletion of the gene encoding CD59, a membrane protein that inhibits the formation of the membrane attack complex (MAC).
  • A polymorphism in the promoter region of the C5 gene leading to reduced transcription and synthesis of C5 protein yet without impacting serum C5 levels.
  • An increased expression of Factor H leading to unchecked inactivation of C3 convertase.

A researcher is investigating the effects of a novel cytokine on T helper cell differentiation. They observe that T helper cells exposed to this cytokine in vitro exhibit increased expression of GATA-3, enhanced IL-4 and IL-5 production, and improved B cell help in antibody production. This cytokine MOST likely shares functional properties with which established cytokine involved in adaptive immunity?

<p>Interleukin-4 (IL-4) (B)</p> Signup and view all the answers

A patient with rheumatoid arthritis is treated with a novel biologic agent that selectively inhibits the signaling of TNF-alpha and IL-1. While the patient experiences significant relief from joint inflammation, they also develop a severe, disseminated Mycobacterium tuberculosis infection, despite having a previously negative tuberculosis skin test. What immunological mechanism BEST explains this increased susceptibility to tuberculosis?

<p>Inhibition of TNF-alpha and IL-1 impairs the activation of macrophages and formation of granulomas, both critical for containing <em>Mycobacterium tuberculosis</em> infection. (B)</p> Signup and view all the answers

A researcher is designing an attenuated vaccine against a novel virus. To enhance the cellular immune response and long-term immunity, they plan to incorporate an adjuvant. Which adjuvant strategy would be MOST effective in stimulating cytotoxic T lymphocyte (CTL) responses and promoting cross-presentation of viral antigens?

<p>Including unmethylated CpG oligonucleotides (TLR9 agonists) to activate plasmacytoid dendritic cells and induce type I interferon production. (D)</p> Signup and view all the answers

A patient undergoing immunosuppressive therapy following a solid organ transplant develops a severe Pneumocystis jirovecii pneumonia (PCP). The patient's immunosuppression regimen includes tacrolimus, azathioprine, and corticosteroids. Which of the following mechanisms LEAST likely contributes to the increased susceptibility to PCP in this patient population?

<p>Azathioprine directly inhibits the production of complement components, reducing opsonization and phagocytosis of <em>Pneumocystis</em> organisms. (C)</p> Signup and view all the answers

A researcher is investigating the sequence of events in a novel immune response to a newly identified pathogen. They observe that antigen-presenting cells (APCs) efficiently capture and process the antigen, but T cell activation is significantly impaired. Further analysis reveals a defect in the interaction between the peptide-MHC complex and the T cell receptor (TCR). Which of the following mechanisms BEST explains this observed impairment in T cell activation?

<p>A polymorphism in the gene encoding CD3, resulting in a structurally abnormal CD3 protein that is unable to properly transduce the activation signal. (D)</p> Signup and view all the answers

In the context of a prototypical immune response, the initiation of B lymphocyte activation requires two crucial signals. If a B cell successfully binds to its cognate antigen via its B cell receptor (BCR), signaling the first activation event, which of the subsequent immunological events is absolutely essential to provide the second signal, particularly if the antigen is a soluble protein?

<p>Uptake and processing of the antigen by the B cell, presentation of the processed peptide via MHC class II to a cognate T helper cell, and subsequent co-stimulation and cytokine secretion by the T helper cell. (C)</p> Signup and view all the answers

Following activation, cytotoxic T lymphocytes (CTLs) employ various mechanisms to eliminate target cells expressing foreign antigens. If a CTL exhibits normal expression of perforin and granzymes, but demonstrates impaired cytotoxic activity against target cells in vivo, what is the MOST plausible explanation for this functional defect?

<p>Increased expression of PD-1 on the CTL surface, leading to inhibitory signaling upon engagement with PD-L1 on target cells. (B)</p> Signup and view all the answers

Flashcards

Complement System

A system of circulating proteins that function in both the innate and adaptive immunity.

Complement Activation

In innate immunity, activated by the alternative and mannan-binding lectin pathways; adaptive immunity uses the classical pathway.

Classical Pathway of Complement

Activated by antigen-antibody (IgG, IgM) complex binding C1, C1 activates C2 and C4.

Mannan-binding Lectin (MBL) pathway

MBL proteins bind to mannose on microbes, activating MASP which activates C2, C4, and C3.

Signup and view all the flashcards

Alternative Pathway

Initiated by microbe cell-surface components, spontaneous C3 breakdown, factor B/D cleave C3b.

Signup and view all the flashcards

Terminal/Lytic Pathway

Attachment of C5b to bacterial membrane initiates membrane attack complex (MAC), ultimately causing cell lysis.

Signup and view all the flashcards

Functions of Complement

Opsonization, lysis, inflammation, and B cell activation.

Signup and view all the flashcards

Cytokines

Proteins secreted by immune cells in response to microbes that stimulate growth and differentiation of lymphocytes.

Signup and view all the flashcards

Adjuvants

Substances that enhance the immune response.

Signup and view all the flashcards

Immunomodulation

Adjustment of immune response to a desired level.

Signup and view all the flashcards

Study Notes

Complement System

  • Circulating and membrane-associated proteins function in both innate and adaptive immunity
  • Components are C1 through C9, factor B, D, and P
  • Fragments of the components can be cleaved into 2, and indicated by a lowercase letter like C5a, C5b, C4a, etc

Complement Activation

  • In innate immunity, activation can occur via the alternative pathway or the mannan-binding lectin pathway
  • In adaptive immunity, activation occurs via the classical pathway

Classical Pathway

  • Activated by antigen-antibody (IgG, IgM) complexes
  • C1q, r, and s components bind to the Ag-Ab complex, leads to C1 activation
  • C1 acts as an enzyme and cleaves C2 and C4
  • C4b + 2b forms the C3 convertase C4b2b to cleave C3
  • Binding of C3b to C4b2b results in C4b2b3b, which is the C5 convertase that cleaves C5 into C5a & C5b to initiate the membrane attack complex

Mannan-Binding Lectin (MBL) Pathway

  • MBL are serum proteins that bind to specific carbohydrates
  • The pathway is activated by MBL binding to mannose residues of glycoproteins on microbes
  • MBL interacts with 2 MBL-activated serine proteases, MASP1 & MASP2, once bound to mannose
  • MASP activation leads to activation of C2, C4, and C3 like the classical pathway

Alternative Pathway

  • Initiated by cell-surface components of microbes recognized as foreign to the host like LPS
  • Spontaneous breakdown of C3 is the most abundant serum complement component
  • C3b attaches to receptors on microbes
  • C3b binds to factor B
  • Factor B is cleaved by factor D to produce C3bBb, an unstable C3 convertase
  • C3bBb binds properdin factor, factor P, to produce stabilized C3 convertase
  • Additional C3b fragments are added to form C5 convertase C3bBb3b
  • C5 convertase cleaves C5 into C5a and C5b, C5b inserts into the cell membrane to begin the formation of membrane attack complex and cell lysis

Terminal or Lytic Pathway

  • Can be entered from the classical, MBL, or alternative pathway
  • Attachment of C5b to the bacterial membrane initiates the formation of the membrane attack complex (MAC) and lysis
  • C5b attaches to the cell membrane
  • Addition of components C6, C7, and C8 forms C5b678
  • Subsequent addition of multiple C9 molecules, poly C9, form pores in the cell membrane, resulting in cell death
  • The MAC is C5b6789(n)
  • C9 is homologous to "perforin," found in Tc and NK cell granules

Functions of the Complement

  • Opsonization and phagocytosis: C3b, or C4b, act as opsonins
  • Complement-mediated lysis: the membrane attack complex, MAC, creates pores and induce osmotic lysis of cells
  • Stimulation of inflammatory reactions: C5a, C3a, and C4a bind to receptors on neutrophils and stimulate inflammatory reactions
  • C5a, C3a and C4a are chemoattractants to neutrophils
  • Providing stimuli for B cell activation and the humoral immune response

Cytokines

  • Proteins secreted by immune cells in response to microbes
  • Stimulate growth and differentiation of lymphocytes
  • Activate immune cells to eliminate microbes and antigens
  • Stimulate hematopoiesis
  • Used in medicine as therapeutic agents

Cytokine Nomenclature

  • Monokines are from macrophages/monocytes
  • Lymphokines are from lymphocytes
  • Interleukins act on other leucocytes
  • Cytokines may be produced by lymphocytes, monocytes, or any other cell

Classification of Cytokines

  • Mediators and regulators of innate immunity are mainly produced by macrophages and NK cells

  • TNF-α activates neutrophils and inflammation

  • IL-1 activates neutrophils and inflammation

  • IL-12 activates T & NK cells

  • IFN-α and IFN-β have antiviral action and increase expression of class I MHC in all cells

  • Chemokines promote chemotaxis and migration of leukocytes into tissues

  • Mediators and regulators of adaptive immunity are produced by T lymphocytes

  • IL-2 stimulates proliferation of T, NK, and B cells

  • IL-4 causes B cell isotype switch to IgE and mast cell proliferation

  • IL-5 stimulates B cell proliferation and eosinophil activation

  • IFN-γ activates macrophages and increases microbicidal functions

  • Stimulators of hematopoiesis

  • GM-CSF

  • IL-3 and IL-7

Cytokine Therapy

  • Interferon α is in clinical use in viral hepatitis HCV and melanoma
  • Interferon β is used in multiple sclerosis
  • IL-2 is in clinical trials in treatment of tumors
  • GM-CSF is in routine use in cancer patients to promote BM recovery and correct neutropenia
  • TNF and IL-1 antagonists are for rheumatoid arthritis treatment

Immunomodulation

  • Adjustment of the immune response to a desired level, as in immunopotentiation or immunosuppression

Immunopotentiation

  • Enhancement of the immune response by increasing its rate and prolonging its duration through administering an adjuvant

Adjuvants

  • Agents that stimulate the immune system and increase the response to a vaccine, without a specific antigenic effect by itself
  • Inorganic adjuvants include aluminium salts
  • Organic adjuvants include squalene
  • Oil-based adjuvants:
    • Complete Freund's adjuvant is a water-in-oil emulsion containing killed Mycobacteria
    • Incomplete Freund's adjuvant is a water-in-oil emulsion without Mycobacterium
  • Virosomes: A virosome is a phospholipid bilayer vesicle containing hepatitis A and Influenzas antigens
  • Cytokines like IL-12

Mechanisms of Action of Adjuvants

  • Prolong retention of the immunogen
  • Increase the size of immunogen and promote phagocytosis and presentation by macrophages
  • Stimulate the influx of macrophages and other immune cells to the injection site
  • Increase local cytokine production

Immunosuppression

  • Suppression of the immune system
  • Indications include hypersensitivity responses, autoimmune diseases, and post-transplantation to prevent rejection
  • Induction by drugs, radiation, and anticancer drugs

Methods of Immunosuppression in Clinical Use

  • Cyclosporine and tacrolimus (FK-506) are fungal macrolides
  • Inhibit T cell activation by blocking T cell cytokine production, IL-2
  • The most commonly used immunosuppressive drugs for prevention of graft rejection, but tacrolimus is less nephrotoxic than cyclosporin
  • Azathioprine and mycophenolate mofetil are antiproliferative drugs that inhibit synthesis of purines required for cell division and block lymphocytes proliferation
  • Corticosteroids are anti-inflammatory drugs, inhibit the secretion of proinflammatory cytokines, and decreases the migration of inflammatory cells

Specific Immunosuppressants

  • Anti-CD3 monoclonal antibody depletes T cells by binding to CD3 molecules
  • Anti-IL-2 receptor antibody inhibits T cell proliferation by blocking IL-2 binding to its receptor

Prototypical Immune Response Events

  • Triggered when an antigen enters the body and encounters APCs
  1. APCs capture an amount of the antigen by phagocytosis
  2. APCs process the antigens into very small fragments or peptides
  3. APCs present antigens plus class II MHC molecules to T helper cells
  4. Binding of peptide-MHC complex to TCRs activates helper T lymphocytes

Immune Response Events (cont.)

  • Secretion of cytokines: Secreted by the activated TH cells. IL-2 is one of the cytokines that act on the producing TH, which leads to their proliferation and activation. INF-y activates macrophages & phagocytosis.

  • While TH cells are being activated: B cells recognize and bind antigens through their BCRs, and it needs two signals to be activated

  • The one is the Ag binding to the BCR

  • The second one is provided by helper factors like cytokines secreted by TH cells

  • Activated B lymphocytes can differentiate into memory B lymphocytes or plasma cells which secrete antibodies

  • Activation of cytotoxic T cells

  • Tc lymphocytes recognize Ag on the surface of the target cell, such as a virus-infected cell

  • Tc cell activation requires IL-2 & IFN-γ from a nearby activated Th cell

  • The activated CTLs kill the target cell

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

More Like This

Use Quizgecko on...
Browser
Browser